OXALIPLATIN
Oxawind

OXAWIND is indicated for use in combination with infusional 5-FU/LV for the adjuvant treatment of patients with Stage III colon cancer who have undergone complete resection of the primary tumor, and for the treatment of advanced carcinoma of the colon or rectum.

Packaging: Box of 1’s
Shelf Life: 24 months
Origin: India
Dosage Form: Solution for Injection